Genmab

	10/1 11:16 af gentogen	Thanks.From the transscript about Dara: "we think we still have 50% of the market to be able to expand"...
	10/1 11:14 af E L	as rumoured here on PI ;-) - 6/12 12:37 af E L ESMO Immuno-Oncology 2023 Poster online- HexaBody-OX40, a novel Fc_ receptor crosslinking-independent OX40-targeting antibody, exhibits agonistic activity in vitro and antitumor activity in vivo (link) "A first-in-human clinical trial is planned " I am assuming this is the #6 in the BioNTech cooperation.
	10/1 11:13 af E L	BioNTech presentation @ J.P. Morgan Healthcare Conference Prof. Ugur Sahin, M.D. 9 January 2024 (link) -->confirms HexaBody-OX40 is next , GEN1055 / BNT315
	10/1 10:45 af E L	EDITED TRANSCRIPT JNJ.N - Johnson & Johnson at JPMorgan Healthcare Conference JANUARY 08, 2024 (link)
	10/1 07:31 af Stroka	God morgen :-)
	10/1 07:00 af Helge Larsen/PI-redaktør	Godmorgen :-)
	9/1 14:51 af ProInvestorNEWS	Genmab tager skridt mod fuld godkendelse af middel mod livmoderhalskræft i USA (link)
	9/1 14:13 af E L	"Based on emerging clinical data, the companies have planned engagement with health authorities on the design of a Phase 3 trial for BNT311/GEN1046 (acasunlimab) in second line NSCLC. The companies intend to share the data on which this decision was based at a medical conference in 2024."
	9/1 14:11 af E L	BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference (link)
	9/1 13:47 af ProInvestorNEWS	TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug (link)
	9/1 11:47 af E L	JPM24: As cancer players jump head-first into ADC field, Novartis CEO explains how he's resisted the temptation (link)
	9/1 10:17 af E L	Novartis indicates Kesimpta Peak sales (approx.) $4bn
	9/1 10:16 af E L	Novartis Strategy & Growth Update from J.P. Morgan Healthcare Conference (link)
	9/1 09:53 af E L	that is great to hear! 10 years already...just amazing!
	9/1 09:29 af Monforte	#EL, yes, still going strong, planning 10-years anniversary with the DARA-treatment in june without any complications.
	9/1 09:10 af JKY_VH	Tak PN 7:47, så er der 14% upside ifølge canadiske RBC og god morgen;-)
	9/1 08:47 af ProInvestorNEWS	Kursmålet for Genmab sænkes med 14 pct. af canadisk finanshus (link)
	9/1 08:16 af ProInvestorNEWS	Tirsdagens danske avisuddrag med Vestas, Pandora og Genmab (link)
	9/1 08:05 af Darvin	“Don’t forget that what we care about is percentage gains, not incremental gains,” he said. “And I think we can find bigger percentage gains in health care,
	9/1 08:05 af Darvin	According to Cramer, health-care companies can yield bigger percentage gains than tech companies, for which investors should be looking. He also pointed out the large number of multibillion-dollar biopharma acquisitions announced at the end of 2023, saying investors should be on the lookout for more industry mergers. 9/1 2024 07:03 af Darvin “Don’t forget that what we care about is percentage gains, not incremental gains,” he said. “And I think we can find bigger percentage gains in health care
	9/1 08:04 af Darvin	Cramer flytter fokus til Health Car
	9/1 07:53 af bibob	God morgen. :-)
	9/1 07:37 af Stroka	God morgen :-)
	9/1 07:03 af Helge Larsen/PI-redaktør	Godmorgen :-)

	9/1 07:02 af Solsen	Hvis Carvykti slettes af listen i MM pga utilsigtede bivirkninger står Genmab godt og det kan være det JNJ forbereder investorerne på.Hvis JNJ taber voldgiften eller er interesseret i hexa-38 er der kun et alternativ for dem ;-)
	8/1 22:59 af E L	JPM24: Johnson & Johnson CEO says Tecvayli, Talvey and several other meds are set to trounce analyst estimates (link)
	8/1 22:56 af E L	But now that we have you here Monforte, everything still going well for you?
	8/1 22:55 af E L	i am not the patient here, just posting that blog; sorry if i confused that, i probalby shouldn't have copied that title directly....
	8/1 21:42 af Solsen	Worth more than money !
	8/1 21:40 af Solsen	Good to hear your treatment succedeed EL Nice being shareholder to a co who created epco, dara etc :-)
	8/1 21:31 af Monforte	#EL, tillykke med din behandling og det gode resultat!
	8/1 21:13 af Pensionisten	Genmab handles pænt op i US . Lige nu i niveau 2224.
	8/1 20:32 af E L	*NOVARTIS IN ADVANCED TALKS TO BUY CYTOKINETICS: WSJ $NVS
	8/1 19:58 af JKY_VH	Enig royal:-D
	8/1 17:32 af royal	Dollar Nohope, og ja for filan, JKY_VH :-)
	8/1 17:27 af gdn55	Også tak herfra
	8/1 17:25 af Plimsoller	Nice and uplifting reading E L. Thank you for the link!
	8/1 16:49 af E L	"I may have been the first CLL patient in this trial, but I understand there is a significant waiting list for the trial now."
	8/1 16:49 af E L	"It’s early, but all seven CLL patients in the European study of epcoritamab who were in complete remission, like me, also achieved undetectable MRD with flow cytometry down to 1 in 10,000 cells."
	8/1 16:48 af E L	"New Year’s Update and Outlook for My Epcoritamab Trial" (link)
	8/1 16:26 af JKY_VH	Er vi så klar med "Ja-hatten" royal?
	8/1 16:04 af nohope	Hviken slags milliarder ?
	8/1 15:49 af royal	Har JnJ 40 milliarder til at købe for?
	8/1 15:46 af royal	Herreste gud. Småpenge, men rigtig god præmie. :-)
	8/1 15:16 af ProInvestorNEWS	Johnson & Johnson i milliardopkøb på kræftområdet (link)
	8/1 14:41 af E L	Merck buying a small Tcell engager biotech, Harpoon Therapeutics (link)
	8/1 14:38 af E L	JNJ buying another ADC biotech , Ambrx (link)
	8/1 14:34 af E L	Novartis interested in Interleukin-15 (link) -we can't be too far away from getting data on PRV-015 i would imagine, maybe towards the summer
	7/1 10:23 af JKY_VH	Velbekomme, ja lad os håbe det;-)
	7/1 08:43 af Klarussen	Godmorgen :-) @JKY: Tak for den. Det kan blive et meget spændende 2024 som Genmab aktionær.